Camel milk as an adjuvant therapy for the treatment of type 1 diabetes: verification of a traditional ethnomedical practice - PubMed

Affiliations

• PMID: 19459752
• DOI: 10.1089/jmf.2008.0009

Randomized Controlled Trial

Camel milk as an adjuvant therapy for the treatment of type 1 diabetes: verification of a traditional ethnomedical practice

Ragaa Hosny Mohamad et al. J Med Food. 2009 Apr.

Abstract

There is a traditional belief in the Middle East that regular consumption of camel milk may aid in prevention and control of diabetes. The aim of this work was to evaluate the efficacy of camel milk as an adjuvant therapy in young type 1 diabetics. This 16-week randomized study enrolled 54 type 1 diabetic patients (average age 20 years) selected from those attending the outpatient diabetes clinic of the Menofia University Hospital, affiliated with Egypt's National Cancer Institute. Subjects were randomly divided into two groups of 27 patients: one received usual management (diet, exercise, and insulin), whereas the other received 500 mL of camel milk daily in addition to standard management. A control group of 10 healthy subjects was also assessed. The following parameters were evaluated at baseline and at 4 and 16 weeks: hemoglobin A1c (HbA1c), human C-peptide, lipid profile, serum insulin, anti-insulin antibodies, creatinine clearance, albumin in 24-hour urine, body mass index, and Diabetes Quality of Life score. The following parameters were significantly different between the usual-management group versus the camel milk group after 16 weeks: fasting blood sugar (227.2 +/- 17.7 vs. 98.9 +/- 16.2 mg/dL), HbA1c (9.59 +/- 2.05[%] vs. 7.16 +/- 1.84[%]), serum anti-insulin antibodies (26.20 +/- 7.69 vs. 20.92 +/- 5.45 microU/mL), urinary albumin excretion (25.17 +/- 5.43 vs. 14.54 +/- 5.62 mg/dL/24 hours), daily insulin dose (48.1 +/- 6.95 vs. 23 +/- 4.05 units), and body mass index (18.43 +/- 3.59 vs. 24.3 +/- 2.95 kg/m(2)). Most notably, C-peptide levels were markedly higher in the camel milk group (0.28 +/- 0.6 vs. 2.30 +/- 0.51 pmol/mL). These results suggest that, as an adjunct to standard management, daily ingestion of camel milk can aid metabolic control in young type 1 diabetics, at least in part by boosting endogenous insulin secretion.

Similar articles

• Effect of camel milk on glycemic control and insulin requirement in patients with type 1 diabetes: 2-years randomized controlled trial.

  Agrawal RP, Jain S, Shah S, Chopra A, Agarwal V. Agrawal RP, et al. Eur J Clin Nutr. 2011 Sep;65(9):1048-52. doi: 10.1038/ejcn.2011.98. Epub 2011 Jun 1. Eur J Clin Nutr. 2011. PMID: 21629270 Clinical Trial.

• Camel milk ameliorates hyperglycaemia and oxidative damage in type-1 diabetic experimental rats.

  Meena S, Rajput YS, Pandey AK, Sharma R, Singh R. Meena S, et al. J Dairy Res. 2016 Aug;83(3):412-9. doi: 10.1017/S002202991600042X. J Dairy Res. 2016. PMID: 27600979

• Camel milk as an adjunct to insulin therapy improves long-term glycemic control and reduction in doses of insulin in patients with type-1 diabetes A 1 year randomized controlled trial.

  Agrawal RP, Beniwal R, Kochar DK, Tuteja FC, Ghorui SK, Sahani MS, Sharma S. Agrawal RP, et al. Diabetes Res Clin Pract. 2005 May;68(2):176-7. doi: 10.1016/j.diabres.2004.12.007. Epub 2005 Feb 24. Diabetes Res Clin Pract. 2005. PMID: 15860247 Clinical Trial. No abstract available.

• Medical benefits of camel's milk: A comprehensive review.

  Al Nohair SF. Al Nohair SF. J Pak Med Assoc. 2021 Mar;71(3):933-937. doi: 10.47391/JPMA.367. J Pak Med Assoc. 2021. PMID: 34057952 Review.

• Camel milk: a possible boon for type 1 diabetic patients.

  Agrawal RP, Tantia P, Jain S, Agrawal R, Agrawal V. Agrawal RP, et al. Cell Mol Biol (Noisy-le-grand). 2013 Nov 3;59(1):99-107. Cell Mol Biol (Noisy-le-grand). 2013. PMID: 24200025 Review.

Cited by

• The Application of Natural Camel Milk Products to Treat Autism-Spectrum Disorders: Risk Assessment and Meta-Analysis of Randomized Clinical Trials.

  Kandeel M, El-Deeb W. Kandeel M, et al. Bioinorg Chem Appl. 2022 May 27;2022:6422208. doi: 10.1155/2022/6422208. eCollection 2022. Bioinorg Chem Appl. 2022. PMID: 35669459 Free PMC article. Retracted.

• Processing Challenges and Opportunities of Camel Dairy Products.

  Berhe T, Seifu E, Ipsen R, Kurtu MY, Hansen EB. Berhe T, et al. Int J Food Sci. 2017;2017:9061757. doi: 10.1155/2017/9061757. Epub 2017 Oct 3. Int J Food Sci. 2017. PMID: 29109953 Free PMC article. Review.

• Effect of Camel Milk on Glucose Homeostasis in Patients with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

  AlKurd R, Hanash N, Khalid N, Abdelrahim DN, Khan MAB, Mahrous L, Radwan H, Naja F, Madkour M, Obaideen K, Abu Shihab K, Faris M. AlKurd R, et al. Nutrients. 2022 Mar 15;14(6):1245. doi: 10.3390/nu14061245. Nutrients. 2022. PMID: 35334901 Free PMC article. Review.

• Hypoglycemic effect of camel milk powder in type 2 diabetic patients: A randomized, double-blind, placebo-controlled trial.

  Zheng Y, Wu F, Zhang M, Fang B, Zhao L, Dong L, Zhou X, Ge S. Zheng Y, et al. Food Sci Nutr. 2021 Jun 29;9(8):4461-4472. doi: 10.1002/fsn3.2420. eCollection 2021 Aug. Food Sci Nutr. 2021. PMID: 34401094 Free PMC article.

• Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions.

  Kanwar JR, Roy K, Patel Y, Zhou SF, Singh MR, Singh D, Nasir M, Sehgal R, Sehgal A, Singh RS, Garg S, Kanwar RK. Kanwar JR, et al. Molecules. 2015 May 26;20(6):9703-31. doi: 10.3390/molecules20069703. Molecules. 2015. PMID: 26016555 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information